Standing Order
Alnylam Pharmaceuticals, Inc.

Dashboard

Alnylam Pharmaceuticals, Inc.

ALNYNASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$19B
Price$143.8252w $143.82 – $491.22
Conviction5/ 5
Revenue (TTM)$5.0B
Revenue growth YoY+56.2%
P/E (trailing)7.1
Gross margin77.3%
Operating margin19.5%
Net margin54.3%
52w price change-53.0%
Next earnings—

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Nov 17
    Ownership changeSEC

    Form 4 insider transaction filing dated 2026-11-17.

  • Nov 12
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Nov 12
    Ownership changeSEC

    Form 4 insider ownership change filing.

  • Nov 12
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Nov 5
    LeadershipSEC

    8-K filed with items 5.02 and 8.01 on 2026-11-05 regarding director or officer matters.

  • Oct 29
    Financial resultsSEC

    Alnylam filed 8-K (items 2.02, 9.01) reporting financial results.

  • Oct 6
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 22
    OtherSEC

    SEC Form 4 insider transaction filing.

  • Jul 30
    Financial resultsSEC

    Filed 8-K (items 2.02, 9.01) disclosing results of operations and financial condition.

  • Jun 3
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership by an insider at Alnylam Pharmaceuticals.

  • Jun 3
    Ownership changeSEC

    SEC Form 4 insider transaction filing

  • May 27
    LeadershipSEC

    8-K (items 5.02, 5.07) reports officer/director changes and shareholder vote results from 2026-05-20 meeting.

  • May 22
    Ownership changeSEC

    SEC Form 4 insider ownership filing.

  • May 22
    Ownership changeSEC

    SEC Form 4 insider ownership filing.

  • May 22
    Ownership changeSEC

    Form 4 insider ownership filing

  • May 22
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • May 22
    Ownership changeSEC

    SEC Form 4 filing reporting change in beneficial ownership by insider.

  • May 22
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • May 22
    Ownership changeSEC

    SEC Form 4 filed reporting change in beneficial ownership.

  • May 22
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

Not financial advice — research and opinion only. Disclosures